FT : Merger talks between advert sites 58.com and Ganji.com


New York-listed 58.com and a second Chinese online marketplace have agreed to merge, as consolidation accelerates in the local technology sector.
A memorandum of understanding between 58.com and Ganji.com, which both function much like US site Craigslist, was signed in Beijing on March 14, people familiar with the matter said.
The two groups are expected to announce as soon as Wednesday that they are planning to combine to create what will become one of the largest specialised online classified companies in China’s booming mobile internet space. The combined group could be valued at as much as $10bn, one person involved in the transaction said.

Because of antitrust concerns the transaction will probably involve two stages. Currently 58.com is about twice as big as Ganji.com, but both companies provide a range of online advertising listings including job adverts, housing and second-hand goods.
Last year, internet giant Tencent bought a 20 per cent stake in 58.com, and the online marketplace announced last month that it had acquired Shanghai-based property-listing platform Anjuke Inc for about $267m in cash and shares.
Haoyong Yang, the founder of Ganji.com, will become one of the co-chief executives along with Jinbo Yao, founder of 58.com, the person said.
By joining forces, the two hope to reduce marketing costs substantially. Each spend about $250m a year on such efforts, one investor said. US-based private equity firms have stakes in both groups, with Warburg Pincus an investor in 58.com while Carlyle, Sequoia and Tiger Global, among others, have stakes in Ganji.
The latest merger comes at a time when investors are very bullish about Chinese internet shares but are also concerned that many of the sector’s companies are burning too much cash as they subsidise their operations to attract customers.
“People are fighting over the market,” said one leading tech investor. “There is so much money thrown at these companies that they are virtually paying people to use their services. The money is not being used efficiently.”
The merger plans come at a time when some western investors in mainland Chinese internet firms are starting to pressure the management to place more focus on shareholder value.
“Many companies make decisions on the basis of ego of their founders, not economics,” this investor added. “Even when they only have small stakes in their companies.”
In some cases, that has led to merger talks.
Last summer, two of China’s leading online taxi services, Kuadi Dache, which is part owned by Alibaba, and Didi Dache, part owned by Alibaba’s bitter rival Tencent, ended their price war and agreed to combine.
“It was like Romeo and Juliet getting married with the blessing of both sets of parents,” this person added.
The planned listing of Alibaba’s financial operations in China this year is expected to give rise to another bout of frenzied activity in the space.

>>> UBI says no talks with Monte Paschi, no rush on M&A - RTRS

UBI says no talks with Monte Paschi, no rush on M&A - RTRS

(Reuters) - The chief executive of UBI Banca UBI.MI, Italy's fifth biggest lender, said on Tuesday there were no contacts with Monte dei Paschi di Siena BMPS.MI over a possible tie-up and signalled he was in no rush to take part in sector consolidation.
Bankers say UBI is the most likely domestic candidate to take over troubled Monte dei Paschi, who has been told by the European Central Bank to find a buyer quickly because of its fragile state.
Victor Massiah said his bank would start thinking about consolidation after a shareholder meeting that will convert the bank into a joint-stock company, something that is expected to happen from September onwards, and in any case within 18 months.

(WP) Big pharmaceutical companies are spending far more on marketing than resear

Have a look to this chart, impressive

Big pharmaceutical companies are spending far more on marketing than research

Prescription drugs are a massive market: Americans spent $329.2 billion on prescription drugs in 2013. That works out to about $1,000 per person in the U.S., as John Oliver pointed out in his show on Sunday night.
Oliver also mentioned that nine out of 10 big pharmaceutical companies spend more on marketing than on research. León Markovitz of Dadaviz found and graphed those figures from healthcare research firm GlobalData in the graphic below. The amounts spent on sales and marketing are shown in orange, while the amounts spent on research and development are in blue.
The biggest spender, Johnson & Johnson, shelled out $17.5 billion on sales and marketing in 2013, compared with $8.2 billion for R&D. In the top 10, only Roche spent more on R&D than on sales and marketing.
Most of this marketing money is directed at the physicians who do the prescribing, rather than consumers. As Oliver pointed out, drug companies spent more than $3 billion a year marketing to consumers in the U.S. in 2012, but an estimated $24 billion marketing directly to health care professionals.
Oliver closed his segment with a hilarious spoof commercial that urges patients to ask their doctors how pharmaceutical marketing might be influencing them.
"Ask your doctor today if he's taking pharmaceutical company money. Then ask your doctor what the money is for," the narrator says. "Ask your doctor if he's taken any money from the companies who make the drugs he just prescribed for you. Then ask yourself if you're satisfied with that answer."

(ING) Altice - No fear Alti(ce)tude, Raised TP to €127

We raise our TP to €127 and keep Altice on our ING Benelux favourites list as we believe: 
(1) synergies from NUM-SFR will beat expectations; 
(2) Altice shares offer a potential 14% upside pa over 2015-18F at current scope; 
(3) Altice has the financial headroom to make more value-added acquisitions.

SOTP raised to €127. We raise our SOTP-based TP to €127, mainly driven by: 
(1) a higher valuation for France, as we have gained confidence that NUM-SFR will expand EBITDA margins towards 46% by 2021F (previously 42%). Note that our SOTP no longer includes a 55% probability that NUM-SFR will acquire Bouygues Telecom; and 
(2) a higher valuation for Portugal, as Portugal Telecom’s (PT) FY14 results beat our expectations, allowing us to
raise our 2015F EBITDA by c.6%.

...Full note attached

(Le Figaro) JP Morgan et les frères Zaoui à la manoeuvre dans le dossier Alcatel

JP Morgan et les frères Zaoui à la manoeuvre dans le dossier Alcatel Lucent/Nokia

Nokia et Alcatel Lucent ont confirmé ce mardi être en discussions en vue d'un rapprochement qui devrait prendre la forme d'une offre publique d'échange du finlandais sur les actions du groupe franco-américain.
Une opération pour laquelle les deux entreprises ont déjà des banques conseils. Selon nos informations, c'est un géant mondial, l'américain JP Morgan, qui conseille Nokia. Tout l'inverse côté Alcatel Lucent, qui a pris les services de la «boutique» des frères Zaoui, Yoel et Michaël. Logique, puisque Yoel Zaoui a longtemps travaillé chez Goldman Sachs avec Jean Raby, aujourd'hui directeur financier d'Alcatel. D'autres banques pourraient venir renforcer les équipes de négociation et de montage de cette opération dans les heures ou les jours qui viennent.

(BFW) Nokia Is Being Advised by JP Morgan, Le Figaro Says


BFW 04/14 11:25 *ALCATEL IS BEING ADVISED BY ZAOUI BROTHERS, LE FIGARO SAYS
BFW 04/14 11:24 *NOKIA IS BEING ADVISED BY JP MORGAN, LE FIGARO SAYS

Nokia Is Being Advised by JP Morgan, Le Figaro Says
2015-04-14 11:31:00.328 GMT


By David Whitehouse
(Bloomberg) -- Alcatel is being advised by the Zaoui
brothers, Le Figaro reports, without saying where it got the
information.
Story: {http://bit.ly/1JGoZhp}
* NOTE: Nokia in Talks to Acquire Network-Equipment Rival
Alcatel {NMSJLM6TTDS2 <GO>}



Link to Company News:{ALU FP <Equity> CN <GO>}
Link to Company News:{JPM US <Equity> CN <GO>}
Link to Company News:{NOK1V FH <Equity> CN <GO>}

For Related News and Information:
First Word scrolling panel: {FIRST<GO>}
First Word newswire: {NH BFW<GO>}

To contact the editor responsible for this story:
David Whitehouse at +33-1-5365-5059 or
dwhitehouse1@bloomberg.net